Sökning: onr:"swepub:oai:DiVA.org:uu-512653" >
Iron Deficiency in ...
Iron Deficiency in Heart Failure and Effect of Dapagliflozin : Findings From DAPA-HF.
-
Docherty, Kieran F. (författare)
-
Welsh, Paul (författare)
-
Verma, Subodh (författare)
-
visa fler...
-
De Boer, Rudolf A. (författare)
-
O’Meara, Eileen (författare)
-
Bengtsson, Olof (författare)
-
Kober, Lars (författare)
-
Kosiborod, Mikhail N. (författare)
-
Hammarstedt, Ann (författare)
-
Langkilde, Anna Maria (författare)
-
Lindholm, Daniel (författare)
-
Little, Dustin J. (författare)
-
Sjostrand, Mikaela (författare)
-
Martinez, Felipe A. (författare)
-
Ponikowski, Piotr (författare)
-
Sabatine, Marc S. (författare)
-
Morrow, David A. (författare)
-
Schou, Morten (författare)
-
Solomon, Scott D. (författare)
-
Sattar, Naveed (författare)
-
Jhund, Pardeep S. (författare)
-
McMurray, John J. V. (författare)
-
visa färre...
- 2022
- 2022
- Engelska.
-
Ingår i: Circulation. ; 146:13, s. 980-994
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: Iron deficiency is common in heart failure and associated with worse outcomes. We examined the prevalence and consequences of iron deficiency in the DAPA-HF trial (Dapagliflozin and Prevention of Adverse- Outcomes in Heart Failure) and the effect of dapagliflozin on markers of iron metabolism. We also analyzed the effect of dapagliflozin on outcomes, according to iron status at baseline. METHODS: Iron deficiency was defined as a ferritin level $<$100 ng/mL or a transferrin saturation $<$20% and a ferritin level 100 to 299 ng/mL. Additional biomarkers of iron metabolism, including soluble transferrin receptor, erythropoietin, and hepcidin were measured at baseline and 12 months after randomization. The primary outcome was a composite of worsening heart failure (hospitalization or urgent visit requiring intravenous therapy) or cardiovascular death. RESULTS: Of the 4744 patients randomized in DAPA- HF, 3009 had ferritin and transferrin saturation measurements available at baseline, and 1314 of these participants (43.7%) were iron deficient. The rate of the primary outcome was higher in patients with iron deficiency (16.6 per 100 person-years) compared with those without (10.4 per 100 person-years; P$<$0.0001). The effect of dapagliflozin on the primary outcome was consistent in iron-deficient compared with iron- replete patients (hazard ratio, 0.74 [95% CI, 0.58-0.92] versus 0.81 [95% CI, 0.63-1.03]; P-interaction=0.59). Similar findings were observed for cardiovascular death, heart failure hospitalization, and all-cause mortality. Transferrin saturation, ferritin, and hepcidin were reduced and total iron-binding capacity and soluble transferrin receptor increased with dapagliflozin compared with placebo. CONCLUSIONS: Iron deficiency was common in DAPA-HF and associated with worse outcomes. Dapagliflozin appeared to increase iron use but improved outcomes, irrespective of iron status at baseline. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT03036124.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- *Heart Failure/complications/drug therapy/epidemiology
- *Iron Deficiencies
- anemia
- Benzhydryl Compounds
- Biomarkers
- erythropoiesis
- ferritin
- Ferritins
- Glucosides
- heart failure
- hepcidin
- Hepcidins
- Humans
- iron
- Iron
- Receptors
- Erythropoietin/therapeutic use
- Receptors
- Transferrin
- sodium-glucose cotransporter 2 inhibitor
- Stroke Volume
- transferrin
- Transferrins/pharmacology/therapeutic use
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Docherty, Kieran ...
-
Welsh, Paul
-
Verma, Subodh
-
De Boer, Rudolf ...
-
O’Meara, Eileen
-
Bengtsson, Olof
-
visa fler...
-
Kober, Lars
-
Kosiborod, Mikha ...
-
Hammarstedt, Ann
-
Langkilde, Anna ...
-
Lindholm, Daniel
-
Little, Dustin J ...
-
Sjostrand, Mikae ...
-
Martinez, Felipe ...
-
Ponikowski, Piot ...
-
Sabatine, Marc S ...
-
Morrow, David A.
-
Schou, Morten
-
Solomon, Scott D ...
-
Sattar, Naveed
-
Jhund, Pardeep S ...
-
McMurray, John J ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
- Circulation
- Av lärosätet
-
Uppsala universitet